Navigation Links
Assured Pharmacy, Inc. Receives Gross Proceeds of $300,000 from Sale of Convertible Debentures and Warrants
Date:12/8/2010

FRISCO, Texas, Dec. 8, 2010 /PRNewswire-FirstCall/ -- Assured Pharmacy, Inc. (Pink Sheets: APHY) (the "Company"), a growing chain of specialty pharmacies that provides advanced prescription services to a diverse array of medical professionals and their patients, announced today that it sold in a private placement to an accredited investor a 12.5% senior convertible debenture for an aggregate principal amount of $300,000 (before deducting expenses and fees related to the private placement).  The debentures are convertible into shares of the Company's common stock at an initial conversion price of $0.008 per share, subject to adjustment.  As part of the private placement, the investor received a warrant to purchase 45,000,000 shares of the Company's common stock.  The warrant is exercisable for a period of three years from the date of issuance at an initial exercise price of $0.0096, subject to adjustment.  The investor may exercise the warrant on a cashless basis if the shares of common stock underlying the Warrant are not then registered pursuant to an effective registration statement.  The funds received from the investor will be directed to the continued development of the Company's business plan and general working capital purposes.  

This financing is supporting the Company's ongoing business expansion and investment into solidifying its supply chain of prescription medications.  "We are very pleased to have the support of this investment as we enter the next phase of our business model," stated Mr. Robert DelVecchio, Chief Executive Officer of Assured Pharmacy.  "As we lay the foundation for expanding our pharmacy footprint into new markets, improving our financial position with suppliers is critical and this financing furthers that requirement."

The securities sold by the Company in the private placement were not registered
'/>"/>

SOURCE Assured Pharmacy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Assured Pharmacy Reports Same Store Sales for the Month of September 2010
2. Assured Pharmacy Engages UHY, LLP As Auditors
3. Assured Pharmacy Reports Same Store Sales for the Month of August 2010
4. Assured Pharmacy Receives $500,000 in Debt Financing
5. Assured Pharmacy Reports Same Store Sales for the Month of July 2010
6. Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device
7. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
8. Caliper Continues Participation in EPAs Expanded ToxCast Program; Receives Remaining Phase II Compounds for Screening in Fourth Quarter
9. Varespladib Receives 2010 European Society Pediatric Research Award
10. QuantaLife, Inc. Receives Tax Credit for Development of Droplet Digital™ PCR
11. Caraco Receives Sun Pharma Proposal to Purchase All Outstanding Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Hill-Rom Holdings, Inc. ... to a management presentation at the Morgan Stanley Global ... EDT. You are invited to listen to ... http://ir.hill-rom.com/events.cfm or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP ... available one hour after conclusion of the live event ...
(Date:8/27/2014)... DANVERS, Mass. , Aug. 27, 2014 North ... with a prestigious R&D 100 Award for the new OSRAM ... laser and LED-based white light module for microscopy, endoscopy and ... Xenon lamps with significantly higher efficacy and lamp life. ... as one of the most innovative new technologies of ...
(Date:8/27/2014)... Aug. 27, 2014 Amgen (NASDAQ: ... Administration (FDA) has granted priority review designation for ivabradine ... is an oral drug that inhibits the I ... node, the body,s cardiac pacemaker. 1 Ivabradine works ... myocardial contractility or ventricular repolarization. 1 Heart failure ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7
... First U.S. Clinical Data on XIENCE V ... Follow-Up,Results from the ABSORB Bioabsorbable Stent Clinical ... /PRNewswire-FirstCall/ --,Abbott will present data from several ... during a number of late-breaking,clinical trial and ...
... La Jolla,Pharmaceutical Company today announced updated interim antibody,reduction ... (abetimus,sodium), its drug candidate for systemic lupus erythematosus,("lupus" ... that there is a definitive and significant dose ... mg doses of Riquent compared,with placebo (p=0.0001). These ...
Cached Medicine Technology:Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 2Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 3Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 4Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 5La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6
(Date:8/27/2014)... August 28, 2014 The report provides ... (Laser designator, Laser Range Finder, LIDAR, 3D scanner, Laser ... Laser Doppler Vibrometer, Laser Altimeter) by Domain (Aerospace, Defense ... - 2020” published by MarketsandMarkets, and its application in ... The global Military Laser Systems market is expected to ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Spine Guide ... online source of information on spinal health. Now, the ... pain, or people suffering from back pain symptoms. Spine ... surgery, cervical/neck surgery, and lumbar spine surgery. , Some ... ache, shooting or stabbing pain, pain radiating down the ...
(Date:8/27/2014)... 27, 2014 DentistSave.com , ... has launched in the state of Tennessee to ... affordable dental care services at reduced rates. DentistSave.com ... consumers looking to save money on their dental ... a member of discount fee dental plan available ...
(Date:8/27/2014)... DC (PRWEB) August 28, 2014 The ... Betty Pierce Dennis, DrPH, MN, RN, FAAN, became the ... Center for the Advancement of the Science of Nursing ... of seven that comprise the NLN Home for Transformative ... nation’s capital a year ago. , Under Dr. ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 National ... participate in the Association for Medical Education in Europe ... in Milan, Italy August 30 – September 3, 2014. ... of the international medical education community, share the benefits ... to strengthen resident physician placement in countries throughout the ...
Breaking Medicine News(10 mins):Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4Health News:National Resident Matching Program International (NRMPI) to Exhibit at the 2014 AMEE Conference 2
... of transmission of senile amyloidosis to offspring from affected ... to child// have been raised. Details about the scientific ... AApoAII amyloidosis,' by Korenaga et al., can be cited ... Pathology. ,Dementia can result from several disease ...
... who wear seat belts show better chances of recovery even ... ,The research has revealed that of the 24,000 car accident ... three times more likely to die in the hospital than ... and his colleagues at the Medical College of Wisconsin in ...
... College London have found that by boosting up the levels of ... reduced appetite and higher activity levels, with the only side effect ... what tells our brains whether we're full after a meal, but ... this hormone than those who do not put on weight. They ...
... of Obstetrics and Gynecology has advocated the use of ... relief// after a cesarean section. The researchers say that ... morphine. ,Using these drugs for pain relief ... undesirable side effects such as nausea and drowsiness for ...
... motor neurone disease can be reduced by around 60 percent, ... or vitamin E, according to a new study. ,In ... in vegetable oils such as corn oil and omega 3 ... ,The motor neurone diseases (MND) are a group of progressive ...
... a portable water filtration system, powered by bicycle that ... Technological University's (NTU) institute of environmental science and engineering ... a mechanical pump and a membrane module to filter ... first, NTU experts said it is an improvement on ...
Cached Medicine News:Health News:Doubts About In UteroTransmission Of Senile Amyloidosis 2Health News:A New Study Shows That A Hormone Could Lead To Weight Loss 2Health News:Polyunsaturated Fat, Vitamin E Lowers Risk Of Motor Neurone Disease 2
... Most practitioners consider the HOPE nebulizer the ... have been made to put everything together in ... The result is our #11320 Adult HOPE Kit ... corrugated tubing and pediatric aerosol mask all in ...
... medication nebulizers offer a spill-proof design and ... a 45° angle. All medical nebulizers are ... variety of configurations are available., ,All ... ,Portex® medication nebulizers feature consistently fine ...
... delivery of medication as well as humidification, ... closed dilution, high volume, continuous medication nebulizer ... to patients. Its 200 ml reservoir and ... 8 hours of nebulized medication delivery at ...
... Products, ,Westmed designs, manufacturers and markets ... Respiratory professionals. Our mission is to design ... ability to deliver quality medical care while ... , ,Our web site is designed ...
Medicine Products: